Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition containing pokeberry antiviral proteins and immunologic active material and applications thereof

An immune active and antiviral technology, applied in the field of medicine, can solve problems such as long wound healing time, scab bleeding, cervical dilatation barriers, etc.

Inactive Publication Date: 2018-09-11
海南森瑞谱生命科学药业股份有限公司
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although physical therapy is effective, there are disadvantages such as increased vaginal secretions for a long time after surgery, large trauma, a large amount of watery discharge and scab bleeding, long wound healing time, high recurrence rate, and high cost. receiving physical therapy
At the same time, trauma sometimes leaves permanent scars, which may lead to atresia of secretory glands, changes in cervical mucus, infertility, or obstruction of cervical dilatation during childbirth, leading some patients to refuse treatment due to their desire for fertility or fear of surgery
In addition to CIN and VIN, for VAIN patients, the current clinical effects of physical therapy such as surgery or laser are not ideal
In addition, three different lesions of CIN, VAIN and VIN can also exist at the same time, and physical therapy such as surgery is not ideal for the treatment of patients with the combination of two or three lesions of CIN, VAIN and VIN
[0009] Pokeweed antiviral proteins (pokeweed antiviral proteins, PAPs) are one of the active ingredients in pokeweed, and PAPs have antiviral effects. The pharmaceutical composition of pokeweed antiviral proteins and immune active substances is used in female lower genital tract epithelium There is no report on the treatment of internal neoplasia, especially in patients with VAIN and patients with two or three lesions of CIN, VAIN and VIN.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing pokeberry antiviral proteins and immunologic active material and applications thereof
  • Pharmaceutical composition containing pokeberry antiviral proteins and immunologic active material and applications thereof
  • Pharmaceutical composition containing pokeberry antiviral proteins and immunologic active material and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Pokeweed antiviral protein 0.1g, coconut oil 3g, Cordyceps extract 1g, Ganoderma lucidum extract 1g, polyinosinic acid-polycytidylic acid 1g, CMC-Na 3g, glycerin 10g, chlorhexidine 0.15g, purified water plus to 100g.

Embodiment 2

[0021] Pokeweed antiviral protein 0.5g, seaweed polysaccharide 2g, Ganoderma lucidum extract 0.1g, aloe vera gel powder 10g, polyinosinic acid-polycytidylic acid 0.1g, carbomer 1g, glycerin 10g, triethanolamine 1g, polysorbate 1 g of alcohol, 0.05 g of ethyl p-hydroxybenzoate, an appropriate amount of 95% ethanol, and purified water to 100 g.

Embodiment 3

[0023] Pokeweed antiviral protein 0.08g, Cordyceps extract 2g, Ganoderma lucidum extract 0.5g, propolis 1g, polyinosinic acid-polycytidylic acid 0.5g, carrageenan 6g, mix well, and make a compound agent with solvent before use.

[0024] The batch numbers of the medicines prepared in the above three examples are 1209001, 1209002, and 1209003, and the preparation techniques of the three examples adopt conventional techniques.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition containing pokeberry antiviral proteins and an immunologic active material. The pharmaceutical composition comprises 0.001 to 10 wt% of pokeberry antiviral proteins and 0.1 to 60 wt% of immunologic active material, which is composed of one or more of algal polysaccharides, a cordyceps sinensis extract, a lucid ganoderma extract, propolis, aloe gel powder, polyinosinic acid-polycytidylic acid, and coconut oil. The pharmaceutical composition can effectively treat intraepithelial neoplasia of lower genital tracts of women and is a novel drug for the patients and doctors.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a pharmaceutical composition, in particular to a pharmaceutical composition containing pokeweed antiviral protein and immune active substances and its new application. The pharmaceutical composition can treat female lower genital tract intraepithelial neoplasia, Facilitate outcomes. Background technique [0002] Female lower genital tract intraepithelial neoplasia, including cervical intraepithelial neoplasia (CIN), vaginal intraepithelial neoplasia (VAIN), vulvar intraepithelial neoplasia (VIN), three Lesions in different parts can exist at the same time. [0003] According to the degree and extent of atypical hyperplasia, cervical intraepithelial neoplasia (CIN) is divided into grades I, II, and III. CIN I (called mild dysplasia of cervical epithelium): mild cellular atypia, manifested as enlarged nucleus in the lower 1 / 3 layer of the epithelial layer, slightly increased nucleocytoplasm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K38/16A61K31/715A61K36/068A61K36/074A61K35/644A61K36/896A61K36/886A61K36/889A61K31/713A61P15/00A61P35/00
CPCA61K31/713A61K31/715A61K35/644A61K36/068A61K36/074A61K36/886A61K36/889A61K36/896A61K38/168A61K45/06A61P15/00A61P35/00A61K2300/00
Inventor 张春发邓柳红王桂玉王胜黄超高海波陈一萍
Owner 海南森瑞谱生命科学药业股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products